ethyl 3-(4-(2-ethoxy-2-oxoethyl)-2-((hydroxyimino)methyl)-1H-pyrrol-3-yl)propanoate

ID: ALA561169

Chembl Id: CHEMBL561169

Max Phase: Preclinical

Molecular Formula: C14H20N2O5

Molecular Weight: 296.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)CCc1c(CC(=O)OCC)c[nH]c1/C=N/O

Standard InChI:  InChI=1S/C14H20N2O5/c1-3-20-13(17)6-5-11-10(7-14(18)21-4-2)8-15-12(11)9-16-19/h8-9,15,19H,3-7H2,1-2H3/b16-9+

Standard InChI Key:  YLTJAIDCLNBPHP-CXUHLZMHSA-N

Alternative Forms

  1. Alternative Forms:

    ALA561169

    ---
  2. Parent:

    ALA561169

    ---

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

lef Anthrax lethal factor (7585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPG071 DNA polymerase (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 296.32Molecular Weight (Monoisotopic): 296.1372AlogP: 1.42#Rotatable Bonds: 8
Polar Surface Area: 100.98Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.71CX Basic pKa: 2.42CX LogP: 1.42CX LogD: 1.42
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.33Np Likeness Score: -0.12

References

1. Johnson SL, Chen LH, Barile E, Emdadi A, Sabet M, Yuan H, Wei J, Guiney D, Pellecchia M..  (2009)  Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,  17  (9): [PMID:19359184] [10.1016/j.bmc.2009.03.040]
2.  (2015)  Therapeutic compounds for blocking DNA synthesis of POX viruses,